Insider Transactions Reported by 26 Insiders of Senti Biosciences, Inc.

Symbol
SNTI on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Senti Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Celadon Partners SPV 24 10%+ Owner $21,998,250 10 Mar 2025
New Enterprise Associates 15, L.P. 10%+ Owner $8,495,134 10 Mar 2025
BAYER HEALTHCARE LLC 10%+ Owner $6,322,158 10 Mar 2025
Curt A. Herberts III Chief Operating Officer $1,984,889 08 Jun 2022
Timothy K. Lu CEO, Director $603,660 09 Mar 2026
Deborah Knobelman Chief Financial Officer, Head of Corporate Development $572,470 01 Feb 2024
Kanya Rajangam Pres. & Chief Med. & Dev. Off. $60,622 09 Mar 2026
Donald F. Tang Director $45,308 25 Jun 2025
Dynamics Sponsor LLC Director, 10%+ Owner 08 Jun 2022
Mostafa Ronaghi Chief Executive Officer, Director 25 May 2021
Flatley Jay T. Director 25 May 2021
Mark Afrasiabi Chief Financial Officer 25 May 2021
Dipchand Nishar Director 25 May 2021
Rowan E. Chapman Chief Business Officer 25 May 2021
Brenda Cooperstone Director 25 Jun 2025
John Harry Cross III Chief Financial Officer 07 Mar 2025
Susan D. Berland Director 16 Jun 2023
Mathers Edward T. Director 25 Jun 2025
Fran Schulz Director 25 Jun 2025
Bryan Daniel Baum Director 18 Jul 2025
David R. Epstein Director 13 Jul 2022
Yvonne Li Interim CFO 04 May 2024
Omid Farokhzad Director 10 Jul 2024
James J. Collins Director 25 Jun 2025
Feng Hsiung Director 25 Jun 2025
Philip J. Lee Chief Technology Officer 01 Feb 2023

Recent Insider Transactions by Companies or Individuals for Senti Biosciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Kanya Rajangam SNTI Common Stock Tax liability -12.6% -10,757 74,843 09 Mar 2026 Direct
Timothy K. Lu SNTI Common Stock Tax liability -11.2% -80,666 639,583 09 Mar 2026 Direct
Timothy K. Lu SNTI Common Stock Tax liability -0.58% -4,191 720,249 02 Feb 2026 Direct
Kanya Rajangam SNTI Common Stock Tax liability -1.59% -1,384 85,600 02 Feb 2026 Direct
Bryan Daniel Baum SNTI Stock Option (Right to Buy) Award 43,900 43,900 18 Jul 2025 Direct
James J. Collins SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
Feng Hsiung SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
Fran Schulz SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
Brenda Cooperstone SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
Donald F. Tang SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
Mathers Edward T. SNTI Stock Option (Right to Buy) Award 21,950 21,950 25 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.